Eastwood Bio-Medical Canada Inc.
EWOOF · OTC
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |
|---|---|---|---|---|
| Revenue | $868 | $1,300 | $981 | $718 |
| % Growth | -33.2% | 32.5% | 36.6% | – |
| Cost of Goods Sold | $320 | $397 | $523 | $539 |
| Gross Profit | $548 | $903 | $458 | $180 |
| % Margin | 63.2% | 69.5% | 46.7% | 25% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $667 | $657 | $654 | $747 |
| SG&A Expenses | $670 | $660 | $671 | $781 |
| Sales & Mktg Exp. | $3 | $3 | $16 | $34 |
| Other Operating Expenses | -$122 | $243 | -$212 | -$601 |
| Operating Expenses | $548 | $903 | $458 | $180 |
| Operating Income | -$505 | -$129 | -$596 | -$852 |
| % Margin | -58.2% | -10% | -60.7% | -118.6% |
| Other Income/Exp. Net | -$41 | -$21 | -$8 | -$1 |
| Pre-Tax Income | -$547 | -$150 | -$604 | -$852 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$547 | -$150 | -$604 | -$852 |
| % Margin | -63% | -11.5% | -61.5% | -118.7% |
| EPS | -0.006 | -0.002 | -0.009 | -0.012 |
| % Growth | -185% | 77.3% | 29% | – |
| EPS Diluted | -0.006 | -0.002 | -0.009 | -0.012 |
| Weighted Avg Shares Out | 68,893 | 68,935 | 68,947 | 68,897 |
| Weighted Avg Shares Out Dil | 68,886 | 68,886 | 68,886 | 68,886 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $28 | $11 | $3 | $2 |
| Depreciation & Amortization | $108 | $107 | $105 | $106 |
| EBITDA | -$411 | -$32 | -$496 | -$746 |
| % Margin | -47.3% | -2.5% | -50.5% | -103.9% |